Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 316 AL 330

Alzheimer's disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs

Monteiro AR, Barbosa DJ, Remião F, Silva R.

Biochem Pharmacol. 2023 May;211:115522. doi: 10.1016/j.bcp.2023.115522. Epub 2023 Mar 28.

The Importance of Dopamine Deficiency Evaluation in Non-Alzheimer Disease Dementias

Alkharisi B, Dostzada K, Kaur H, Kumar M, Wei JY, Azhar G.

Am J Case Rep. 2023 Apr 5;24:e938344. doi: 10.12659/AJCR.938344.

Longitudinal head-to-head comparison of (11)C-PiB and (18)F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease

Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, Xiong C, Pontecorvo MJ, Klein G, Su Y, Klunk WE, Jack C, Koeppe R, Snider BJ, Berman SB, Roberson ED, Brosch J, Surti G, Jiménez-Velázquez IZ, Galasko D, Honig LS, Brooks WS, Clarnette R, Wallon D, Dubois B, Pariente J, Pasquier F, Sanchez-Valle R, Shcherbinin S, Higgins I, Tunali I, Masters CL, van Dyck CH, Masellis M, Hsiung R, Gauthier S, Salloway S, Clifford DB, Mills S, Supnet-Bell C, McDade E, Bateman RJ, Benzinger TLS; DIAN-TU Study Team.

Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.

Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review

Twarowski B, Herbet M.

Int J Mol Sci. 2023 Mar 30;24(7):6518. doi: 10.3390/ijms24076518.

The Senior Companion Program Plus (SCP Plus): Examining the Preliminary Effectiveness of a Lay Provider Program to Support African American Alzheimer's Disease and Related Dementias (ADRD) Caregivers

Xu L, Fields NL, Williams IC, Gaugler JE, Kunz-Lomelin A, Cipher DJ, Feinhals G.

Int J Environ Res Public Health. 2023 Apr 3;20(7):5380. doi: 10.3390/ijerph20075380.

Repetitive transcranial magnetic stimulation may be superior to drug therapy in the treatment of Alzheimer's disease: A systematic review and Bayesian network meta-analysis

Wei N, Liu H, Ye W, Xu S, Lu C, Dai A, Hou T, Zeng X, Wu J, Chen J.

CNS Neurosci Ther. 2023 Oct;29(10):2912-2924. doi: 10.1111/cns.14228. Epub 2023 Apr 23.

Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB

Jamalian S, Dolton M, Chanu P, Ramakrishnan V, Franco Y, Wildsmith K, Manser P, Teng E, Jin JY, Quartino A, Hsu JC; Alzheimer's Disease Neuroimaging Initiative.

CPT Pharmacometrics Syst Pharmacol. 2023 Jul;12(7):1029-1042. doi: 10.1002/psp4.12974. Epub 2023 May 2.

Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report

Castellani RJ, Shanes ED, McCord M, Reish NJ, Flanagan ME, Mesulam MM, Jamshidi P.

J Alzheimers Dis. 2023;93(2):803-813. doi: 10.3233/JAD-221305.

Small-molecule theranostics in Alzheimer's disease

Sarabia-Vallejo Á, López-Alvarado P, Menéndez JC.

Eur J Med Chem. 2023 Jul 5;255:115382. doi: 10.1016/j.ejmech.2023.115382. Epub 2023 Apr 21.

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter

LaBarbera KM, Sheline YI, Izzo NJ, Yuede CM, Waybright L, Yurko R, Edwards HM, Gardiner WD, Blennow K, Zetterberg H, Börjesson-Hanson A, Morgan R, Davis CS, Guttendorf RJ, Schneider LS, DeKosky S, LeVine H 3rd, Grundman M, Caggiano AO, Cirrito JR, Catalano SM, Hamby ME.

Transl Neurodegener. 2023 May 12;12(1):24. doi: 10.1186/s40035-023-00358-w.

Recent developments in the chemical biology of amyloid-β oligomer targeting

Wang Y, Chen J, Gao F, Hu M, Wang X.

Org Biomol Chem. 2023 Jun 7;21(22):4540-4552. doi: 10.1039/d3ob00509g.

miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease

Elzayat EM, Shahien SA, El-Sherif AA, Hosney M.

J Alzheimers Dis. 2023;94(s1):S203-S225. doi: 10.3233/JAD-221298.

[The German S3 guidelines on dementia]

Jessen F, Bohr L, Kruse C, Dodel R.

Nervenarzt. 2023 Jul;94(7):609-613. doi: 10.1007/s00115-023-01492-6. Epub 2023 May 26.

Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine

Botchway BOA, Liu X, Zhou Y, Fang M.

J Transl Med. 2023 May 27;21(1):351. doi: 10.1186/s12967-023-04220-5.

Rehabilitation effects of game therapy in people living with dementia: A systematic review and meta-analysis: Three formats of game therapy for Alzheimer's patients

Li J, Guo Y, Yang K, Zhang G, Huang K, Zhou J, Sun Y, Wang Z.

Worldviews Evid Based Nurs. 2023 Aug;20(4):361-376. doi: 10.1111/wvn.12648. Epub 2023 Jun 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias